| June 2005 | ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | ||
| May Jul | ||||||
For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.
C H A N N E L S
• PULSE Home
Page
•
EXECUTIVE
EDITION
•
US News
•
Canada
News
•
UK News
•
New
Zealand News
•
Consumer
Advocacy
•
Health
Care Systems
•
Managed
Care/Medicaid
•
Co-occurring
Disorders
•
Clinical
studies
•
Pharmaceutical
News
•
Criminal
Justice Systems
•
Legislative
News
U S E R ' S G
U I D E
About
PULSE
PULSE Channels
Archives
Adding comments
Using the # link
Items that require registration
PULSE syndication
Tips for Searching PULSE
E M A I L S
U B S C R I P T I O N S
For WEEKLY summaries
of PULSE postings, see the weekly
email subscription form.
For DAILY mailings (powered
by Bloglet), please enter your e-mail address below:
PULSE ANNUAL No. 2
January 2003
Recent
Trends, Challenges and Issues in Funding Public Mental Health Services
in the US
March 2002
PULSE ANNUAL No. 1
October 2001
PULSE is powered by
Radio Userland.
© Bill Davis, 2000-2003.
![]()
Children inherit psychopathic antisocial behavior Story at Psychiatric Matters - "Antisocial behavior in children with high psychopathic tendencies, such as a lack of remorse or understanding for the feelings of others, appears to be largely inherited, say investigators. In contrast, antisocial behavior in children who do not show psychopathic traits tends to be determined by environmental factors. The findings point to the need for intervention strategies for antisocial behavior to be employed early, in the pre-school years, Essi Viding, from the Institute of Psychiatry in London, UK, and colleagues report in the Journal of Child Psychology and Psychiatry."
Medical editors: One-sided drug reviews hard to swallow USA Today story - "Drug companies' marketing efforts may sometimes be more subtle than pens emblazoned with their product's name or full-page ads in leading medical journals. Some journal editors say they regularly receive submissions that appear to be written by the drugmakers' marketing machines, not the scientists whose names appear as authors. Such a practice would violate the guidelines of the Pharmaceutical Research and Manufacturers of America, or PhRMA, the prescription drug industry's trade group, on the communication of clinical trial results..."
Despite Vow, Drug Makers Still Withhold Data Front page New York Times article - " When the drug industry came under fire last summer for failing to disclose poor results from studies of antidepressants, major drug makers promised to provide more information about their research on new medicines. But nearly a year later, crucial facts about many clinical trials remain hidden, scientists independent of the companies say. Within the drug industry, companies are sharply divided about how much information to reveal, both about new studies and completed studies for drugs already being sold. The split is unusual in the industry, where companies generally take similar stands on regulatory issues." [Viewing New York Times resources requires registration, which is free].![]()